BG103933A - 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate - Google Patents
5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleateInfo
- Publication number
- BG103933A BG103933A BG103933A BG10393399A BG103933A BG 103933 A BG103933 A BG 103933A BG 103933 A BG103933 A BG 103933A BG 10393399 A BG10393399 A BG 10393399A BG 103933 A BG103933 A BG 103933A
- Authority
- BG
- Bulgaria
- Prior art keywords
- ethyl
- methyl
- tetrazol
- tetrahydropyridine
- maleate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention relates to an adjunctive salt of the maleic acid of 2-ethyl-5-(1-methyl-1,2,3,6-tetrahydro-3-pyridyl)-2H- tetrazole, to pharmaceutical compositions containing the adjunctive with acid salt, and to its application in the treatment of disorders caused by dysfunction of the acetylcholine (AcCh) or muscarine system.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK78197 | 1997-07-01 | ||
PCT/DK1998/000294 WO1999001448A1 (en) | 1997-07-01 | 1998-07-01 | 5-(2-ethyl-2h-tetrazol-5-y1)-1-methyl-1,2,3,6-tetrahydropyridine maleate |
Publications (1)
Publication Number | Publication Date |
---|---|
BG103933A true BG103933A (en) | 2000-07-31 |
Family
ID=8097489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103933A BG103933A (en) | 1997-07-01 | 1999-11-30 | 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP0994869A1 (en) |
JP (1) | JP2002507215A (en) |
KR (1) | KR20010014297A (en) |
CN (1) | CN1261361A (en) |
AR (1) | AR013096A1 (en) |
AU (1) | AU735751B2 (en) |
BG (1) | BG103933A (en) |
BR (1) | BR9810331A (en) |
CA (1) | CA2293324A1 (en) |
CO (1) | CO4940483A1 (en) |
EA (1) | EA200000081A1 (en) |
HU (1) | HUP0002876A2 (en) |
IL (1) | IL133093A0 (en) |
IS (1) | IS5278A (en) |
JO (1) | JO2031B1 (en) |
MA (1) | MA25138A1 (en) |
NO (1) | NO996580L (en) |
PE (1) | PE116099A1 (en) |
PL (1) | PL337184A1 (en) |
SK (1) | SK187399A3 (en) |
TN (1) | TNSN98120A1 (en) |
TR (1) | TR199903283T2 (en) |
UY (2) | UY25069A1 (en) |
WO (1) | WO1999001448A1 (en) |
ZA (1) | ZA985498B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
CZ287441B6 (en) * | 1995-11-06 | 2000-11-15 | Lundbeck & Co As H | Pharmaceutical preparation for treating traumatic lesion of brain |
-
1998
- 1998-06-18 AR ARP980102925A patent/AR013096A1/en not_active Application Discontinuation
- 1998-06-24 ZA ZA985498A patent/ZA985498B/en unknown
- 1998-06-25 JO JO19982031A patent/JO2031B1/en active
- 1998-06-25 PE PE1998000563A patent/PE116099A1/en not_active Application Discontinuation
- 1998-06-26 CO CO98036576A patent/CO4940483A1/en unknown
- 1998-06-29 UY UY25069A patent/UY25069A1/en not_active Application Discontinuation
- 1998-06-30 TN TNTNSN98120A patent/TNSN98120A1/en unknown
- 1998-07-01 HU HU0002876A patent/HUP0002876A2/en unknown
- 1998-07-01 JP JP50616699A patent/JP2002507215A/en active Pending
- 1998-07-01 CA CA002293324A patent/CA2293324A1/en not_active Abandoned
- 1998-07-01 PL PL98337184A patent/PL337184A1/en unknown
- 1998-07-01 TR TR1999/03283T patent/TR199903283T2/en unknown
- 1998-07-01 IL IL13309398A patent/IL133093A0/en unknown
- 1998-07-01 MA MA25155A patent/MA25138A1/en unknown
- 1998-07-01 AU AU81020/98A patent/AU735751B2/en not_active Ceased
- 1998-07-01 BR BR9810331-8A patent/BR9810331A/en not_active Application Discontinuation
- 1998-07-01 SK SK1873-99A patent/SK187399A3/en unknown
- 1998-07-01 WO PCT/DK1998/000294 patent/WO1999001448A1/en not_active Application Discontinuation
- 1998-07-01 CN CN98806497A patent/CN1261361A/en active Pending
- 1998-07-01 EP EP98930655A patent/EP0994869A1/en not_active Withdrawn
- 1998-07-01 EA EA200000081A patent/EA200000081A1/en unknown
- 1998-07-01 KR KR1019997012429A patent/KR20010014297A/en not_active Application Discontinuation
- 1998-09-10 UY UY25177A patent/UY25177A1/en not_active Application Discontinuation
-
1999
- 1999-11-30 BG BG103933A patent/BG103933A/en unknown
- 1999-11-30 IS IS5278A patent/IS5278A/en unknown
- 1999-12-30 NO NO996580A patent/NO996580L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU735751B2 (en) | 2001-07-12 |
EA200000081A1 (en) | 2000-08-28 |
PL337184A1 (en) | 2000-08-14 |
TR199903283T2 (en) | 2000-06-21 |
JP2002507215A (en) | 2002-03-05 |
BR9810331A (en) | 2000-09-05 |
CA2293324A1 (en) | 1999-01-14 |
ZA985498B (en) | 1999-01-20 |
CO4940483A1 (en) | 2000-07-24 |
UY25177A1 (en) | 2000-12-29 |
NO996580D0 (en) | 1999-12-30 |
SK187399A3 (en) | 2000-06-12 |
PE116099A1 (en) | 1999-11-23 |
UY25069A1 (en) | 1998-12-21 |
AR013096A1 (en) | 2000-12-13 |
CN1261361A (en) | 2000-07-26 |
NO996580L (en) | 1999-12-30 |
MA25138A1 (en) | 2001-04-02 |
HUP0002876A2 (en) | 2001-06-28 |
EP0994869A1 (en) | 2000-04-26 |
JO2031B1 (en) | 1999-05-15 |
WO1999001448A1 (en) | 1999-01-14 |
TNSN98120A1 (en) | 2005-03-15 |
IL133093A0 (en) | 2001-03-19 |
IS5278A (en) | 1999-11-30 |
AU8102098A (en) | 1999-01-25 |
KR20010014297A (en) | 2001-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69528823D1 (en) | Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten | |
MXPA04002982A (en) | Pyrrolidinone derivatives. | |
CA2297911A1 (en) | Substituted 6-phenylphenanthridines | |
YU59098A (en) | Substituted spiro-piperidine derivatives | |
PT1053256E (en) | Antibodies to death receptor 4 (dr4) and uses thereof | |
MY134806A (en) | Cyclosporins | |
EP1808177A3 (en) | Methods of treatment of mitochondrial disorders | |
ATE300533T1 (en) | 1,2,3,4-TETRAHYDROISOCINOLINE DERIVATIVES AS UROTENSIN II RECEPTOR ANTAGONISTS | |
BG102425A (en) | (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors | |
IL118544A0 (en) | Substituted amino pyridyl and pyrimidine containing compounds | |
TR200000015T2 (en) | Compounds and methods | |
HUT73807A (en) | 5-ht1-like indole derivatives and pharmaceutical compositions containing them | |
CA2250569A1 (en) | Novel phenanthridines substituted in the 6 position | |
EP2213302A3 (en) | DR4 antibodies and uses thereof | |
EP0627221A3 (en) | Substance P antagonists for the treatment of vomiting. | |
WO1999045098A3 (en) | Delivery or proteins into eukaryotic cells with recombinant yersinia | |
BG105256A (en) | Muscarinic agonists and antagonists | |
BG105761A (en) | Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | |
WO2001010408A3 (en) | Aqueous pharmaceutical composition containing moxifloxacin or salts thereof | |
KR100292396B1 (en) | ||
BG103933A (en) | 5-(2-ethyl-2h-tetrazol-5-yl)-1-methyl-1,2,3,6- tetrahydropyridine maleate | |
AP2000001946A0 (en) | Form V1 5,6-Dichloro-2-(isopropylamino)-1-(B-L-Ribofuranosyl)-1H- benzimidazole. | |
NO991734L (en) | Pyrazolinones for the treatment of potency disorders | |
YU46302A (en) | Substituted pyrroles | |
FR2710844B1 (en) | Composition for the treatment or prevention of herpes. |